[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5587 Introduced in House (IH)]
<DOC>
116th CONGRESS
2d Session
H. R. 5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the
regulation of hemp-derived cannabidiol and hemp-derived cannabidiol
containing substances.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 13, 2020
Mr. Peterson (for himself, Mr. Comer, Ms. Pingree, and Mr. Massie)
introduced the following bill; which was referred to the Committee on
Energy and Commerce, and in addition to the Committee on Agriculture,
for a period to be subsequently determined by the Speaker, in each case
for consideration of such provisions as fall within the jurisdiction of
the committee concerned
_______________________________________________________________________
A BILL
To amend the Federal Food, Drug, and Cosmetic Act with respect to the
regulation of hemp-derived cannabidiol and hemp-derived cannabidiol
containing substances.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. REGULATION OF HEMP-DERIVED CANNABIDIOL AND HEMP-DERIVED
CANNABIDIOL CONTAINING SUBSTANCES.
(a) Inclusion in Definition of Dietary Supplement.--Section
201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
321(ff)(3)(B)) is amended in each of clauses (i) and (ii) by inserting
``(other than hemp-derived cannabidiol or a hemp-derived cannabidiol
containing substance)'' after ``an article''.
(b) Prohibited Act.--Section 301(ll) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 331(ll)) is amended by inserting ``(other than
hemp-derived cannabidiol or a hemp-derived cannabidiol containing
substance)'' after ``public''.
SEC. 2. MARKETABILITY STUDY AND REPORT.
(a) Study.--The Secretary of Agriculture, in consultation with
other relevant Federal and State agencies, shall complete a study on
the market and regulatory barriers for producers operating under the
domestic hemp production program specified in part 990 of title 7, Code
of Federal Regulations (as in effect on the date of enactment of this
Act).
(b) Contents of Study.--The study under subsection (a) shall
include--
(1) the costs and requirements for establishing and
operating a hemp testing program, including the costs and
requirements for operating or contracting with a laboratory
approved by the Drug Enforcement Agency;
(2) the costs and requirements for the destruction of hemp
crops determined to be in excess of 0.3 percent delta-9
tetrahydrocannabinol or opportunities for remediation or
alternative uses;
(3) the feasibility of producer compliance with sampling
timetables;
(4) the feasibility of producer compliance with reporting
requirements; and
(5) other known or potential challenges by the
participation of States or producers in the domestic hemp
production program.
(c) Report.--Not later than 1 year after the date of the enactment
of this Act, the Secretary shall submit a report on the study described
in this section to the Committee on Agriculture of the House of
Representatives and the Committee on Agriculture, Nutrition, and
Forestry of the Senate.
<all>